🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
This study will be a phase-1, open-label, placebo-controlled, evaluation of...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2022-02-09
Trial ID
NCT05181709
The primary objective of this sub-study is to obtain de-identified, clinica...
Status
Completed
Location
Arizona Clinical Research Center, Inc.
Start Date
2020-07-21
Trial ID
NCT04473625
Treatments Being Tested
This clinical trial studies whether less fit adults with acute myeloid leuk...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07094750
This research trial establishes a breast tumor tissue repository from core ...
Status
Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2013-11-14
Trial ID
NCT02250352
Treatments Being Tested
This phase II trial tests how well olanzapine works in managing cancer cach...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2024-07-17
Trial ID
NCT05705492
Treatments Being Tested
The purpose of this study is to investigate small intestinal remodeling and...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02288351
Treatments Being Tested
The purpose of this study is to assess the performance and safety of Biolog...
Status
Completed
Location
Stanford University
Start Date
2021-03-26
Trial ID
NCT04788147
Treatments Being Tested
A multi-center, open-label, single ascending dose study to enroll opioid de...
Status
Completed
Location
Vince and Associates Clinical Research
Start Date
2012-07
Trial ID
NCT03002961
The primary objective of this study is to obtain de-identified, clinically ...
Status
Terminated
Location
Mercy Fort Smith
Start Date
2018-12-07
Trial ID
NCT03727009
Treatments Being Tested